Asset Management Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Asset Management Group's GILD Position: Q2 2026 in Review
Asset Management Group increased its Gilead Sciences (GILD) stake by 0.6% in Q2 2026, buying an estimated $1.84K and bringing the position to 2,365 shares worth $299K. The position accounts for 0.04% of the portfolio, ranked #127.
Asset Management Group first reported a position in GILD in Q1 2020 and has held it in 20 quarters since. The position peaked at $697K in Q2 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Asset Management Group held 2,365 shares of Gilead Sciences worth $299K as of Q2 2026.
- Asset Management Group bought 14 Gilead Sciences shares in Q2 2026, an estimated $1.84K.
- Gilead Sciences made up 0.04% of Asset Management Group's portfolio in Q2 2026, its #127 holding.
- Asset Management Group first reported a position in Gilead Sciences in Q1 2020 and has held it in 20 quarters since.
- Asset Management Group's Gilead Sciences position peaked at $697K in Q2 2020.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Asset Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.